Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: EC:6.4.1.1 (
pyruvate carboxylase
)
1,516
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
The effect of
calcitonin
(CT) on calcium content and enzyme activity in the hepatic mitochondria of intact rats was investigated. A single subcutaneous administration of CT (80 MRC mU/100 g BW) produced a significant increase in the content of calcium, the activity of
pyruvate carboxylase
, succinate dehydrogenase and ATPase 15 min after the hormone treatment. The significant increases in calcium content and
pyruvate carboxylase
activity were also observed 30 min after CT administration, while succinate dehydrogenase and ATPase activity began to decrease. A physiological dose of CT (20 MRC mU/100 g BW) caused a marked increase in calcium content and
pyruvate carboxylase
activity but not succinate dehydrogenase of ATPase-activity. The removal of calcium by 10 mM EGTA washing of the mitochondria produced a remarkable reduction in
pyruvate carboxylase
activity increased by CT administration. The addition of calcium ion of 2.5 x 10(-2) - 2.5 x 10(1) nmoles Ca2+ per mg mitochondrial protein produced a marked increase in
pyruvate carboxylase
activity. The present results suggest that calcium taken up by the hepatic mitochondria after CT administration activates
pyruvate carboxylase
.
...
PMID:Calcitonin increases pyruvate carboxylase activity in hepatic mitochondria of rats. 621 4